Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Health: Drugs Pricing

House of Lords written question – answered on 10th July 2013.

Alert me about debates like this

Photo of Lord Clement-Jones Lord Clement-Jones Liberal Democrat

To ask Her Majesty’s Government, further to the Written Answer by Earl Howe on 24 June (WA 93), what assessment they have made of the length of time an evaluation under value-based pricing will take for cancer drugs previously considered but not recommended by the National Institute for Health and Care Excellence.

Photo of Earl Howe Earl Howe The Parliamentary Under-Secretary of State for Health

We expect that the timescale for the value assessment process that the National Institute for Health and Care Excellence (NICE) will apply to drugs under value-based pricing will be broadly similar to that for NICE’s existing single technology appraisal process. Details of the existing process are available on NICE’s website at: STA-proof_6-26-10-09.pdf

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.